| http://www.w3.org/ns/prov#value | - Professor Mark Peakman from King???s College London said: ???MultiPepT1De has some important advantages over current approaches to the prevention of Type 1 diabetes, especially its ability to avoid global immune suppression which is a problem with several other approaches under consideration. ???Peptide immunotherapy is being explored in other diseases, such as allergies and multiple sclerosis, us
|
